Last €71.93 EUR
Change Today -0.16 / -0.22%
Volume 206.7K
EI On Other Exchanges
EN Paris
As of 7:02 AM 04/16/14 All times are local (Market data is delayed by at least 15 minutes).

essilor international (EI) Snapshot

Previous Close
Day High
Day Low
52 Week High
05/24/13 - €89.98
52 Week Low
03/14/14 - €70.51
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for ESSILOR INTERNATIONAL (EI)

Related News

No related news articles were found.

essilor international (EI) Related Businessweek News

No Related Businessweek News Found

essilor international (EI) Details

Essilor International SA designs, manufactures, and sells ophthalmic lenses and ophthalmic optical instruments in North America, Europe, the Asia Pacific, Africa, the Middle East, and Latin America. It offers products for correcting myopia, hypermetropia, astigmatism, and presbyopia. The company operates through three segments: Lenses and Optical Instruments, Equipments, and Readers. The Lenses and Optical Instruments segment offers Varilux range of progressive lenses; Crizal range of lenses with anti-reflective, anti-smudge, and anti-static lenses; Optifog for anti-fog lenses; Xperio for polarized lenses; and Nikon, Transitions, Kodak, and Polaroid photochromic lenses. This segment also designs, develops, distributes, and maintains a range of optical instruments for opticians and prescription laboratories; and vision screening instruments for eye-care professionals, schools, occupational medicine centers, the military, and other institutions. The Equipments segment engages manufactures and sells equipment and consumables, such as digital surfacing machines and anti-reflective lenses for prescription laboratories, and integrated optical chains and lens manufacturers. The Readers segment designs and markets non-prescription reading glasses and sunglasses under the eyewear brands, such as Foster Grant, Sight Station, Magnivision, and Bolon, as well as licenses for brands comprising Ironman, Body Glove, Disney, Field & Stream, Dockers, Reebok, and Nine West. It has a network of 454 prescription laboratories and edging centers, as well as various research and development centers. The company was founded in 1972 and is headquartered in Charenton-le-Pont, France.

55,129 Employees
Last Reported Date: 03/25/14
Founded in 1972

essilor international (EI) Top Compensated Officers

Chairman, Chief Executive Officer, Chairman o...
Total Annual Compensation: €1.8M
Compensation as of Fiscal Year 2012.

essilor international (EI) Key Developments

Essilor Places EUR 800-Million Bond Issue

Essilor International has successfully placed an EUR 800-million bond issue under very favorable terms and conditions. Rated A2 (stable outlook) by Moody's, the issue comprised two fixed-rate tranches: A EUR 500-million tranche of seven-year, with a 1.750% coupon. A EUR 300-million tranche of ten-year, with a 2.375% coupon. This was the lowest coupon ever obtained on an inaugural seven-year issue by a non-financial issuer and the lowest ten-year coupon obtained by a non-financial issuer so far this year. The issue was amply oversubscribed, illustrating investor confidence in Essilor's business model and the quality of its credit profile. It has enabled Essilor to diversify its sources of financing and investor base and to support its growth strategy.

Essilor International Recommends Payment of Dividend from May 27, 2014; Reports Audited Consolidated Earnings Results for the Year Ended December 31, 2013; Provides Revenue Guidance for the Year 2014

The Board of Directors of Essilor International recommended that shareholders approve the payment of a dividend of EUR 0.94 per share (up 6.8%) at the May 7, 2014 Annual Meeting. The dividend will be paid as from May 27, 2014. The company reported audited consolidated earnings results for the year ended December 31, 2013. For the period, the company reported revenue of EUR 5,065 million against EUR 4,989 million a year ago. Operating profit was EUR 843 million against EUR 831 million a year ago. Profit attributable to equity holders of the company was EUR 593 million against EUR 584 million a year ago. Earnings per share were EUR 2.82 against EUR 2.80 a year ago. Profit before tax was EUR 845 million against EUR 837 million a year ago. Contribution from operations was EUR 917 million against EUR 893 million a year ago. Net cash from operating activities was EUR 843 million against EUR 840 million a year ago. Purchase of property, plant and equipment and intangible assets was EUR 297 million against EUR 241 million a year ago. Net debt increased by EUR 132 million to EUR 369 million, representing gearing of less than 10%. Capital expenditure was EUR 297 million. Adjusted earnings per share were EUR 2.82 against EUR 2.72 a year ago. In 2014, the company is aiming for 10% to 12% revenue growth at constant exchange rates and a contribution margin of between 18.2% and 18.6% (excluding new strategic acquisitions) depending on the effective date of consolidation of Transitions Optical and final IFRS adjustments.

Essilor International SA, Board Meeting, Feb 26, 2014

Essilor International SA, Board Meeting, Feb 26, 2014., at 10:00 US Eastern Standard Time. Agenda: To approve the 2013 financial statements.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
EI:FP €71.93 EUR -0.16

EI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Hoya Corp ¥2,995 JPY +74.00
Luxottica Group SpA €41.00 EUR +0.75
Safilo Group SpA €14.19 EUR 0.00
View Industry Companies

Industry Analysis


Industry Average

Valuation EI Industry Range
Price/Earnings 26.2x
Price/Sales 3.0x
Price/Book 4.1x
Price/Cash Flow 26.4x
TEV/Sales 2.6x

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ESSILOR INTERNATIONAL, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at